Harbin Pharmaceutical Group Co Ltd (600664) — Cash Flow Reinvestment Rate
Harbin Pharmaceutical Group Co Ltd (600664) has a Cash Flow Reinvestment Rate of 0.12x as of June 2025, reinvesting CN¥38.54 Million (capex CN¥20.49 Million plus investments CN¥-18.05 Million) from operating cash flow of CN¥323.33 Million. Check earnings quality score of Harbin Pharmaceutical Group Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Harbin Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (1998–2024)
Historical reinvestment intensity for Harbin Pharmaceutical Group Co Ltd across 23 annual periods. Explore investment intensity of Harbin Pharmaceutical Group Co Ltd to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Harbin Pharmaceutical Group Co Ltd (1998–2024)
Year-by-year capital reinvestment analysis for Harbin Pharmaceutical Group Co Ltd. For live market cap and broader valuation context, see Harbin Pharmaceutical Group Co Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.13x | CN¥101.52 Million | CN¥792.50 Million | CN¥100.81 Million | ▲ +39.6% |
| 2023 | 0.09x | CN¥87.12 Million | CN¥949.67 Million | CN¥86.54 Million | ▼ -64.8% |
| 2022 | 0.26x | CN¥161.98 Million | CN¥622.09 Million | CN¥89.65 Million | ▼ -77.6% |
| 2018 | 1.16x | CN¥806.46 Million | CN¥692.72 Million | CN¥114.11 Million | ▲ +31.6% |
| 2017 | 0.88x | CN¥132.01 Million | CN¥149.22 Million | CN¥102.01 Million | ▲ +1236.9% |
| 2016 | 0.07x | CN¥183.82 Million | CN¥2.78 Billion | CN¥107.46 Million | ▼ -65.8% |
| 2015 | 0.19x | CN¥320.75 Million | CN¥1.66 Billion | CN¥290.75 Million | ▼ -41.5% |
| 2014 | 0.33x | CN¥375.37 Million | CN¥1.14 Billion | CN¥375.37 Million | ▼ -87.3% |
| 2013 | 2.61x | CN¥369.90 Million | CN¥141.64 Million | CN¥369.90 Million | ▲ +428.2% |
| 2012 | 0.49x | CN¥275.78 Million | CN¥557.83 Million | CN¥275.78 Million | ▲ +90.5% |
| 2010 | 0.26x | CN¥299.19 Million | CN¥1.15 Billion | CN¥299.19 Million | ▲ +115.3% |
| 2009 | 0.12x | CN¥223.26 Million | CN¥1.85 Billion | CN¥223.26 Million | ▼ -51.2% |
| 2008 | 0.25x | CN¥143.09 Million | CN¥578.59 Million | CN¥143.09 Million | ▼ -8.1% |
| 2007 | 0.27x | CN¥175.00 Million | CN¥650.16 Million | CN¥175.00 Million | ▼ -39.1% |
| 2006 | 0.44x | CN¥326.28 Million | CN¥738.08 Million | CN¥326.28 Million | ▼ -24.5% |
| 2005 | 0.59x | CN¥443.61 Million | CN¥757.76 Million | CN¥443.61 Million | ▼ -79.6% |
| 2004 | 2.88x | CN¥428.60 Million | CN¥149.01 Million | CN¥428.60 Million | ▲ +83.9% |
| 2003 | 1.56x | CN¥473.73 Million | CN¥302.83 Million | CN¥473.73 Million | ▲ +53.4% |
| 2002 | 1.02x | CN¥391.03 Million | CN¥383.44 Million | CN¥391.03 Million | ▼ -3.0% |
| 2001 | 1.05x | CN¥635.28 Million | CN¥604.13 Million | CN¥635.28 Million | ▼ -2.2% |
| 2000 | 1.08x | CN¥582.49 Million | CN¥541.70 Million | CN¥582.49 Million | ▲ +151.4% |
| 1999 | 0.43x | CN¥184.43 Million | CN¥431.22 Million | CN¥184.43 Million | ▼ -6.0% |
| 1998 | 0.45x | CN¥100.73 Million | CN¥221.41 Million | CN¥100.73 Million | — |